Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for ALT
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

28.7

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

-0.05

EPS Last/This Y

0.21

EPS This/Next Y

-0.25

Price

3.92

Target Price

17.75

Analyst Recom

1.67

Performance Q

-17.09

Relative Volume

0.62

Beta

0.01

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08ALT3.70.180.39198096
2025-09-09ALT3.780.190.15199497
2025-09-10ALT3.670.190.31201371
2025-09-11ALT3.680.190.31203752
2025-09-12ALT3.630.190.14204919
2025-09-15ALT3.590.190.64203794
2025-09-16ALT3.640.190.98206493
2025-09-17ALT3.570.1926214663930.58887677208288207441
2025-09-18ALT3.860.190.08208581
2025-09-22ALT3.950.240.11169039
2025-09-23ALT3.80.230.09177076
2025-09-24ALT3.930.230.27179504
2025-09-25ALT3.920.220.38194043
2025-09-26ALT3.980.230.15199893
2025-09-29ALT3.790.230.90194248
2025-09-30ALT3.770.240.45196847
2025-10-01ALT3.860.240.11197514
2025-10-02ALT3.920.240.15203965
2025-10-03ALT3.90.240.12205054
2025-10-06ALT4.010.240.09201615
2025-10-07ALT3.920.240.08202255
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08ALT3.7116.2-75.7-1.13
2025-09-09ALT3.7816.2-88.8-1.13
2025-09-10ALT3.6716.2-72.1-1.13
2025-09-11ALT3.6916.2-83.6-1.13
2025-09-12ALT3.6316.2-76.0-1.13
2025-09-15ALT3.5916.2-77.5-1.13
2025-09-16ALT3.6316.2-85.8-1.13
2025-09-17ALT3.5716.2-76.4-1.13
2025-09-18ALT3.8616.2-112.1-1.13
2025-09-19ALT3.7716.2-74.3-1.13
2025-09-22ALT3.9616.2-99.2-1.13
2025-09-23ALT3.8016.2-69.0-1.13
2025-09-24ALT3.9316.2-94.8-1.13
2025-09-25ALT3.9216.2-86.4-1.13
2025-09-26ALT4.0016.2-88.5-1.13
2025-09-29ALT3.7816.2-64.8-1.13
2025-09-30ALT3.7716.2-80.4-1.13
2025-10-01ALT3.8716.2-90.6-1.13
2025-10-02ALT3.9316.2-87.7-1.13
2025-10-03ALT3.9116.2-80.2-1.13
2025-10-06ALT4.0216.2-90.1-1.13
2025-10-07ALT3.9216.2-74.6-1.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08ALT1.29-1.3829.13
2025-09-09ALT1.29-1.3829.13
2025-09-10ALT1.29-1.3829.13
2025-09-11ALT1.29-1.3830.63
2025-09-12ALT1.29-1.3830.63
2025-09-15ALT0.12-1.3030.63
2025-09-16ALT0.12-1.3030.63
2025-09-17ALT0.12-1.3030.63
2025-09-18ALT0.12-1.3030.63
2025-09-19ALT0.00-1.3030.63
2025-09-22ALT0.00-1.3030.63
2025-09-23ALT0.00-1.3030.63
2025-09-24ALT0.00-1.3030.63
2025-09-25ALT0.00-1.3028.70
2025-09-26ALT0.00-1.3028.70
2025-09-29ALT0.00-1.2828.70
2025-09-30ALT0.00-1.2828.70
2025-10-01ALT0.00-1.2828.70
2025-10-02ALT0.00-1.2828.70
2025-10-03ALT0.00-1.2828.70
2025-10-06ALT0.00-0.5628.70
2025-10-07ALT0.00-0.5628.70
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT 589 360 ]

Last Quarter Act. EPS

-0.27

Avg. EPS Est. Current Quarter

-0.27

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

Institutional Transactions

-0.56

Beta

0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

23

Growth Score

23

Sentiment Score

40

Actual DrawDown %

84.1

Max Drawdown 5-Year %

-91.2

Target Price

17.75

P/E

Forward P/E

PEG

P/S

17342.47

P/B

2.07

P/Free Cash Flow

EPS

-1.18

Average EPS Est. Cur. Y​

-1.13

EPS Next Y. (Est.)

-1.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-438730

Relative Volume

0.62

Return on Equity vs Sector %

-79.6

Return on Equity vs Industry %

-65.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-74.6
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT 589 450 ]
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading